Establishing the maximum safe stimulation parameters for platinum cochlear implant electrode arrays.
建立铂人工耳蜗电极阵列的最大安全刺激参数。
基本信息
- 批准号:9331628
- 负责人:
- 金额:$ 31.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2019-08-30
- 项目状态:已结题
- 来源:
- 关键词:Acoustic NerveAcuteAdoptedAdultAnimalsAreaAuditoryChargeChildChronicClinicClinicalCochleaCochlear ImplantsCommunitiesCustomDevelopmentDevicesElectric StimulationElectrodesElectrophysiology (science)GrowthGuidelinesHearingImplanted ElectrodesIndustry StandardManufacturer NameMeasuresMedicalMetabolicMetabolic stressNeuronsOsteogenesisOutcomePatientsPhasePhysiologic pulsePlatinumPropertyReactionResearchSafetyScala TympaniStimulusSurfaceTechniquesTechnologyTissuesUnited States Food and Drug AdministrationWorkbasedensitydesignexperiencehearing impairmentimprovedinsightinstrumentationneural prosthesisnext generationplatinum electrodepreclinical studypublic health relevancerelating to nervous systemresponse
项目摘要
DESCRIPTION (provided by applicant): Cochlear implants stimulate the auditory nerve using stimuli that minimize the release of toxic electrochemical byproducts and damage associated with metabolic stress of the stimulated neurons. However, these guidelines were based on acute stimulation of cortical neurons and thus do not reflect the safe levels of stimulation for us in a cochlear implant. This application will establish safe stimulation limits specifically for cochlear implants using chronic electrical stimulation. The project will use clinical implants and
electrode fabrication technology to manufacture customized electrode arrays for this research with carefully defined surfaces as small as 0.05 mm2. We hypothesize that safe stimulation levels will be significantly greater than the present levels defined by acute studies. If this hypothesis is correct the next generation of cochlear implants could include smaller electrodes and new stimulation strategies leading to improved clinical outcomes for cochlear implant users. This project has three specific aims: i) establish the threshold stimulus levels for electrochemical damage using platinum electrodes. In this study stimulus rate and charge per phase will be held constant while charge density will be varied from 100-400 µC/cm2/phase using purpose built electrode arrays. The prime measures used to evaluate the extent of electrochemical damage will be the degree of tissue response in stimulated versus control cochleae, neural survival and evidence of electrode degradation; ii) establish the threshold stimulus parameters giving rise to metabolic damage following chronic electrical stimulation of the auditory nerve. This study will co-vary charge per phase (0.39-0.78 µC/phase; i.e. from "safe" to the "unsafe" levels defined acutely), stimulation rate (250 - 1000 pulses per second) and duty cycle (25 - 100%). These combinations will allow us to examine the effects of each parameter independently. Metabolic damage is expected to specifically target auditory neurons and therefore electrophysiological response properties and neural survival will be the primary measures to establish the extent of damage and to define safe limits in both chronically stimulated versus control cochleae; and iii) establish the interaction between electrochemical and metabolic damage by co-varying charge density, charge per phase, stimulation rate and duty cycle around the safe / unsafe boundaries determined in aims i) and ii). These results will allow us to determine the extent of interaction, if any, between the electrochemical and metabolic damage, again impacting on safe stimulation levels.
描述(由应用提供):人工耳蜗使用刺激刺激听觉神经,从而最大程度地减少有毒电化学副产品的释放以及与刺激神经元的代谢应力相关的损伤。但是,这些准则基于对皮质神经元的急性刺激,因此不能反映我们在人工耳蜗中对我们的安全刺激水平。该应用将使用慢性电模拟建立专门针对人工耳蜗的安全刺激极限。该项目将使用临床直接和
电极制造技术,用于制造本研究的定制电极阵列,仔细定义的表面小至0.05 mm2。我们假设安全刺激水平将显着大于急性研究定义的当前水平。如果该假设是正确的,那么下一代的人工耳蜗可能包括较小的电极和新的刺激策略,从而改善了人工耳蜗使用者的临床结果。项目具有三个特定的目的:i)使用铂电极建立电化学损伤的阈值刺激水平。在这项研究中,使用专用的电极阵列,刺激速率和电荷将保持恒定,而电荷密度将与100-400 µC/cm2/phoe不同。用于评估电化学损伤程度的主要措施将是刺激与对照耳蜗的组织反应程度,神经存活以及电极降解的证据。 ii)建立慢性电刺激听觉神经后,建立阈值刺激参数。这项研究将每个阶段共同充电(0.39-0.78 µC/阶段;即从“安全”到急性定义的“不安全”水平),刺激率(每秒250-1000脉冲)和占空比(25-100%)。这些组合将使我们能够独立检查每个参数的效果。预计代谢损伤将专门针对听觉神经元,因此电生理反应的特性和神经生存将是确定损害程度并定义两个长期刺激的损害程度并定义安全限制的主要措施; iii)通过电荷密度,每相电荷,刺激速率和占空比的相互作用建立电化学和代谢损伤之间的相互作用,围绕在目标i)和II中确定的安全 /不安全边界周围。这些结果将使我们能够确定电化学和代谢损害之间的相互作用程度(如果有的话),从而再次影响了安全刺激水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert K Shepherd其他文献
Robert K Shepherd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Innate Immune Response in Cardiac Healing and Rejuvenation
心脏愈合和恢复活力中的先天免疫反应
- 批准号:
10625955 - 财政年份:2023
- 资助金额:
$ 31.16万 - 项目类别:
Commercial translation of high-density carbon fiber electrode arrays for multi-modal analysis of neural microcircuits
用于神经微电路多模态分析的高密度碳纤维电极阵列的商业转化
- 批准号:
10761217 - 财政年份:2023
- 资助金额:
$ 31.16万 - 项目类别:
Annual wellness visit policy: Impact on disparities in early dementia diagnosis and quality of healthcare for Medicare beneficiaries with Alzheimer's Disease and Its Related Dementias
年度健康就诊政策:对患有阿尔茨海默病及其相关痴呆症的医疗保险受益人的早期痴呆诊断和医疗质量差异的影响
- 批准号:
10729272 - 财政年份:2023
- 资助金额:
$ 31.16万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 31.16万 - 项目类别: